Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2017 Mar 1.

Published in final edited form as: Eur J Nucl Med Mol Imaging. 2015 Sep 4;43(3):474–481. doi: 10.1007/s00259-015-3179-2

Fig 2 — a Distribution of VMAT1 and VMAT2 composite protein expression scores in human neuroblastoma tumor samples (n = 74 for VMAT1 and n = 76 for VMAT2). b VMAT1 composite protein expression scores according to MIBG avidity in patients with neuroblastoma (p = 0.76). c VMAT2 composite protein expression scores according to MIBG avidity in patients with neuroblastoma (p = 0.04). For all panels, the longer horizontal dashed lines indicate group medians and the shorter horizontal dashed lines indicate 25^th and 75^th percentiles.

Fig 2 — a Distribution of VMAT1 and VMAT2 composite protein expression scores in human neuroblastoma tumor samples (n = 74 for VMAT1 and n = 76 for VMAT2). b VMAT1 composite protein expression scores according to MIBG avidity in patients with neuroblastoma (p = 0.76). c VMAT2 composite protein expression scores according to MIBG avidity in patients with neuroblastoma (p = 0.04). For all panels, the longer horizontal dashed lines indicate group medians and the shorter horizontal dashed lines indicate 25^th and 75^th percentiles.